Procurement Summary
Country: USA
Summary: Intent to Sole Source Biolegend Oliogos
Deadline: 08 May 2026
Posting Date: 30 Apr 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 140415373
Document Ref. No.: NOI-CC-OLAO-26-004813
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Biolegend.
Acquisition Description:
Custom Oligios needed by PACT team at CCE to do single cell copy number analysis with Tapestri instrument for CAR-T cell products to support clinical QC assay.
The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-OLAO-CC-26-004813) by 12:00 PM eastern standard time on 05/08/2026 to: [email protected].
All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
Notice ID: noi-cc-olao-26-004813
Department/Ind. Agency: health and human services, department of
Sub-tier: national institutes of health
Product Service Code: 6550 - in vitro diagnostic substances, reagents, test kits and sets
NAICS Code: 325414 - Biological Product (except Diagnostic) Manufacturing
Inactive Dates: may 23, 2026
Inactive Policy: 15 days after response date
Documents
Tender Notice